BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3828086)

  • 1. Animal and cellular models of Gaucher's disease. I. Refractoriness of thio analogs of glucocerebroside to enzymatic hydrolysis.
    Quirk JM; Weis AL; Shapiro D; Brady RO
    Biotechnol Appl Biochem; 1986 Feb; 8(1):96-100. PubMed ID: 3828086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocerebroside storage in normal monocyte cultures.
    Hardy B; Teitelman-Weissman B; Chazan S; Neri A
    Biomed Pharmacother; 1987; 41(1):40-4. PubMed ID: 3607254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of rates of hydrolysis of N-oleoyl and N-stearoyl glucocerebroside in patients with Gaucher's disease.
    Peters SP; Aquino L; Naccarato WF; Gilbertson JR; Diven WF; Glew RH
    Biochim Biophys Acta; 1979 Oct; 575(1):27-36. PubMed ID: 508779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors and stimulators of glucocerebroside metabolism.
    Radin NS
    Prog Clin Biol Res; 1982; 95():357-83. PubMed ID: 6214799
    [No Abstract]   [Full Text] [Related]  

  • 5. Gaucher's disease.
    Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahasrabudhe GS; Chole PV
    J Assoc Physicians India; 2009 May; 57():410-1. PubMed ID: 19634291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.
    Brady RO; Pentchev PG; Gal AE; Hibbert SR; Dekaban AS
    N Engl J Med; 1974 Nov; 291(19):989-93. PubMed ID: 4415565
    [No Abstract]   [Full Text] [Related]  

  • 7. The assay of glucocerebrosidase activity using the natural substrata.
    Strasberg PM; Lowden JA
    Clin Chim Acta; 1982 Jan; 118(1):9-20. PubMed ID: 7053909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preclinical research of a new therapy for Gaucher's disease with F213I mutation].
    Hou L; Kousaku O
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):381-4. PubMed ID: 14556188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of synthetic and natural glucosylceramides as substrate for glucosylceramidase assay.
    Vaccaro AM; Kobayashi T; Suzuki K
    Clin Chim Acta; 1982 Jan; 118(1):1-7. PubMed ID: 7053901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3-di-O-tetradecyl-1-O-(beta-D-glucopyranosyl)-sn-glycerol is a substrate for human glucocerebrosidase.
    Glew RH; Gopalan V; Hubbell CA; Devraj RV; Lawson RA; Diven WF; Mannock DA
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):557-63. PubMed ID: 1900989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaucher's disease, chronic adult type: a comparative study of glucocerebroside and methylumbelliferyl-glucopyranoside cleaving potency in leukocytes.
    Klibansky C; Hoffman J; Zaizov R; Matoth Y
    Biomedicine; 1974 Jan; 20(1):24-30. PubMed ID: 4842687
    [No Abstract]   [Full Text] [Related]  

  • 12. The distribution of glucocerebroside in the liver of patients with Gaucher's disease.
    Gal AE; Pentchev PG; Barranger JA; Dambrosia JM; Brady RO
    Anal Biochem; 1979 May; 95(1):127-32. PubMed ID: 495946
    [No Abstract]   [Full Text] [Related]  

  • 13. Gaucher's disease: a case history with extensive lipid storage in the brain.
    Leech RW; Shuman RM; Putnam WD; Rance F; Jewett TT
    Am J Clin Pathol; 1985 Apr; 83(4):516-9. PubMed ID: 3984948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minos-insertion mutant of the Drosophila GBA gene homologue showed abnormal phenotypes of climbing ability, sleep and life span with accumulation of hydroxy-glucocerebroside.
    Kawasaki H; Suzuki T; Ito K; Takahara T; Goto-Inoue N; Setou M; Sakata K; Ishida N
    Gene; 2017 May; 614():49-55. PubMed ID: 28286087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the pathogenesis of Gaucher's disease: tissue distribution and biliary excretion of [14C]L-glucosylceramide in rats.
    Tokoro T; Gal AE; Gallo LL; Brady RO
    J Lipid Res; 1987 Aug; 28(8):968-72. PubMed ID: 3668390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the turnover of exogenous mannose-terminal glucocerebrosidase in rat liver lysosomes.
    Murray GJ; Oliver KL; Jin FS; Brady RO
    J Cell Biochem; 1995 Feb; 57(2):208-17. PubMed ID: 7759558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gaucher's disease: pathogenesis, diagnosis and therapy].
    Pregun I; Tulassay Z
    Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status of enzyme replacement therapy for Gaucher disease.
    Brady RO; Barranger JA; Gal AE; Pentchev PG; Furbish FS
    Birth Defects Orig Artic Ser; 1980; 16(1):361-8. PubMed ID: 7004519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingomyelin and glucocerebroside of spleen in cases of Gaucher's and Niemann-Pick's diseases.
    Taketomi T; Yamakawa T
    Jpn J Exp Med; 1967 Oct; 37(5):505-9. PubMed ID: 5303496
    [No Abstract]   [Full Text] [Related]  

  • 20. Infantile Gaucher's disease: a case with neuronal storage.
    Grafe M; Thomas C; Schneider J; Katz B; Wiley C
    Ann Neurol; 1988 Mar; 23(3):300-3. PubMed ID: 2837134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.